Skip to content

Validity of device-internal AHI detection during OSA therapy with regard to its application in telemonitoring

Validity of device-internal AHI detection during OSA therapy with regard to its application in telemonitoring - Tele-AHI

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00018351
Enrollment
100
Registered
2020-02-12
Start date
2019-04-09
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G47.3

Interventions

Group 1: Comparison of simultaneously measured values of the therapy device with those from the external polygraphic or polysomnographic devices, especially comparison of the number and quality of det

Sponsors

Fachkrankenhaus Kloster Grafschaft GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Polysomnographic or polygraphic control of a device based sleep apnoea therapy with devices of the types AirSense 10 Autoset, AirSense 10 Elite, AirSense 10 Autoset for Her, SOMNObalance, SOMNOsoft 2 oder prismaSMART

Exclusion criteria

Exclusion criteria: Mask leakage >25L/min, therapy duration during recording time 10% of therapy duration

Design outcomes

Primary

MeasureTime frame
The aim of the study is to determine the accuracy of accordance of the device-internal AHI registration with those values detected by standard poly-/somno-/graphic measurement. This accuracy will be expressed as regression analysis and graphically documented by inserting the respective regression line into the cloud of resulting measurement data. The possible deviation in both data sets will be characterized as systematic or dispersed.

Secondary

MeasureTime frame
The accuracy of accordance of the device-internal AHI registration with those values detected by standard poly-/somno-/graphic measurement will be analysed separately for each class of respiratory events (obstructive/central/mixed apnoea, hypopnoea, RERAs) to determine homogeneity in the event detection.

Countries

Germany

Contacts

Public ContactJens Kerl

Fachkrankenhaus Kloster Grafschaft GmbH

j.kerl@fkkg.de02972-7911703

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026